FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/061707 [Registered on: 22/01/2024] Trial Registered Prospectively
Last Modified On: 19/01/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A comparative study of two surfactant administration techniques 
Scientific Title of Study   Comparative evaluation of surfactant administration techniques Less Invasive Surfactant Administration (LISA) vs. Intubation Surfactant Extubation (InSurE) in Preterm Infants with Respiratory Distress Syndrome: A randomized control study 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sukriti Amraik 
Designation  PG 2 year 
Affiliation  School of Medical Sciences and Research and Sharda Hospital 
Address  Department of Pediatrics, School of Medical Sciences and Research, Sharda University, Greater Noida, Gautam Buddha Nagar

Gautam Buddha Nagar
UTTAR PRADESH
201310
India 
Phone  8394832263  
Fax    
Email  sukriti.amraik@sharda.ac.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rajeev Kumar Thapar 
Designation  Head of Department, Professor 
Affiliation  School of Medical Sciences and Research 
Address  Department of Pediatrics, School of Medical Sciences and Research, Greater Noida, Gautam Buddha Nagar

Gautam Buddha Nagar
UTTAR PRADESH
201310
India 
Phone  9839448248  
Fax    
Email  rajeev.thapar@sharda.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr Rajeev Kumar Thapar 
Designation  Head of Department, Professor 
Affiliation  School of Medical Sciences and Research 
Address  Department of Pediatrics, School of Medical Sciences and Research, Greater Noida, Gautam Buddha Nagar

Gautam Buddha Nagar
UTTAR PRADESH
201310
India 
Phone  9839448248  
Fax    
Email  rajeev.thapar@sharda.ac.in  
 
Source of Monetary or Material Support  
Department of Pediatrics, School of Medical Sciences and Research, Greater Noida , 201310 
 
Primary Sponsor  
Name  School of Medical Sciences and Research 
Address  Department of Pediatrics School of Medical Sciences and Research Greater Noida, 201310 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sukriti Amraik  School of Medical Sciences and Research   Department of Pediatrics, NICU, Knowledge Park III Greater Noida 201310
Gautam Buddha Nagar
UTTAR PRADESH 
8394832263

sukriti.amraik@sharda.ac.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
School of Medical Sciences AND Research & Sharda Hospital Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: P220||Respiratory distress syndrome of newborn,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Intubation Surfactant Extubation(InSurE) technique  Preterm neonate with respiratory distress syndrome will be administered surfactant via appropriate ET tube. Dose of surfactant will be calculated as 5ml/kg and administered in 4 aliquots over 1-2 minute.  
Intervention  Less Invasive Surfactant Administration (LISA) technique  Surfactant(Neosurf) will be administered. Dose will be calculated as 5ml/kg. A 5 Fr feeding tube/Surfcath will be placed in the trachea 1–2 cm beyond vocal cords. The surfactant (5ml/kg body weight) will be instilled in 30-60 seconds intratracheally via the catheter. 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  2.00 Day(s)
Gender  Both 
Details  Preterm infants less than 36 weeks which are fulfilling the criteria for RDS and are spontaneously breathing 
 
ExclusionCriteria 
Details  Preterm neonates with
Anatomical abnormalities of upper airway Congenital Diaphragmatic hernia
Choanal atresia
Trachea-oesophageal fistula
Cleft palate
- Requiring intubation with invasive ventilation 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Efficacy of LISA technique over InSurE  At 12 hours, 72 hours, throughout the study time period 
 
Secondary Outcome  
Outcome  TimePoints 
Need for mechanical ventilation  within 72 hours of birth 
need for two or more doses of surfactant   within 12 hours of birth 
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "64"
Final Enrollment numbers achieved (India)="64" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   29/01/2024 
Date of Study Completion (India) 18/11/2024 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="5"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a randomized, parallel group study aimed to do comparative evaluation of surfactant administration techniques - Less Invasive Surfactant Administration (LISA) vs Intubation Surfactant Extubation (InSurE) in preterm infants with respiratory distress syndrome. The study will be conducted in Sharda Hospital, Department of Pediatrics. The primary objective is Comparative evaluation of surfactant administration techniques - Less Invasive Surfactant Administration (LISA) vs Intubation Surfactant Extubation (InSurE) in preterm infants with respiratory distress syndrome and secondary objective is to assess the efficacy of LISA v/s InSurE through pulmonary outcomes –
 Need for mechanical ventilation in the first 72 hours
Days on nCPAP
Need for two or more doses of surfactant
Length of hospital stay
Bronchopulmonary Dysplasia
 
Close